PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16202037-3	2005	The tetracycline-controlled double-transgenic TA(LAP-2)/p(tet)TGF-beta1 mouse provides a model for reversible liver fibrosis.	Tetracycline	4-16	transforming growth factor, beta 1	Mus musculus	62-71	
20616344-1	2010	We recently showed in a tetracycline-controlled transgenic mouse model that overexpression of transforming growth factor (TGF)-beta1 in renal tubules induces widespread peritubular fibrosis and focal degeneration of nephrons.	Tetracycline	24-36	transforming growth factor, beta 1	Mus musculus	94-132	
16386398-2	2006	Recently, we have established a transgenic mouse model with inducible neuron-specific expression of TGF-beta1 based on the tetracycline-regulated gene expression system.	Tetracycline	123-135	transforming growth factor, beta 1	Mus musculus	100-109	
16288910-5	2006	Therefore, to overexpress TGF-beta1 in the artery wall of adult mice, we generated mice that were transgenic for a conditional, tetracycline operator (tetO)-driven TGF-beta1 allele.	Tetracycline	128-140	transforming growth factor, beta 1	Mus musculus	164-173	
16288910-6	2006	These mice were viable, and when crossed with mice expressing a tetracycline-regulated transactivator (tTA) in the heart, expressed the TGF-beta1 transgene in a cardiac-restricted and doxycycline-dependent manner.	Tetracycline	64-76	transforming growth factor, beta 1	Mus musculus	136-145	
15246211-0	2004	Reduction and expansion of the glutamine synthetase expressing zone in livers from tetracycline controlled TGF-beta1 transgenic mice and multiple starved mice.	Tetracycline	83-95	transforming growth factor, beta 1	Mus musculus	107-116	
16029195-4	2005	To overcome these limitations, we established a transgenic mouse model with inducible neuron-specific expression of TGF-beta1 based on the tetracycline-regulated gene expression system.	Tetracycline	139-151	transforming growth factor, beta 1	Mus musculus	116-125	
15246211-1	2004	BACKGROUND/AIMS: To learn more about tissue remodelling in fibrotic livers of tetracycline-controlled TGF-beta1 transgenic mice (TGF-beta1-on-mice) and during regeneration after removal of the fibrotic stimulus (off-mice), we investigated the expression of glutamine synthetase (GS), an exclusive pericentrally expressed enzyme.	Tetracycline	78-90	transforming growth factor, beta 1	Mus musculus	102-111	
12714527-6	2003	Examination of KC mRNA expressed under control of a tetracycline-responsive promoter demonstrated that TGFbeta prevented stabilization of KC mRNA, in response to LPS but did not alter KC mRNA half-life directly.	Tetracycline	52-64	transforming growth factor, beta 1	Mus musculus	103-110	
12717387-0	2003	Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.	Tetracycline	12-24	transforming growth factor, beta 1	Mus musculus	49-58	
12717387-1	2003	Based on the tetracycline-regulated gene expression system, a double-transgenic mouse model for liver fibrosis was established in which the expression of transforming growth factor beta1 (TGF-beta1) can be regulated deliberately by addition or removal of doxycycline hydrochloride to the drinking water.	Tetracycline	13-25	transforming growth factor, beta 1	Mus musculus	154-186	
12717387-1	2003	Based on the tetracycline-regulated gene expression system, a double-transgenic mouse model for liver fibrosis was established in which the expression of transforming growth factor beta1 (TGF-beta1) can be regulated deliberately by addition or removal of doxycycline hydrochloride to the drinking water.	Tetracycline	13-25	transforming growth factor, beta 1	Mus musculus	188-197